CN1712057A - Preparation of succinic acid carbobenzoxy derivative of orchid family plant effective part - Google Patents

Preparation of succinic acid carbobenzoxy derivative of orchid family plant effective part Download PDF

Info

Publication number
CN1712057A
CN1712057A CN 200510081264 CN200510081264A CN1712057A CN 1712057 A CN1712057 A CN 1712057A CN 200510081264 CN200510081264 CN 200510081264 CN 200510081264 A CN200510081264 A CN 200510081264A CN 1712057 A CN1712057 A CN 1712057A
Authority
CN
China
Prior art keywords
preparation
effective site
orchid
benzyl
benzyl succinate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200510081264
Other languages
Chinese (zh)
Inventor
石建功
李帅
杨永春
张建军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Materia Medica of CAMS
Original Assignee
Institute of Materia Medica of CAMS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Materia Medica of CAMS filed Critical Institute of Materia Medica of CAMS
Priority to CN 200510081264 priority Critical patent/CN1712057A/en
Publication of CN1712057A publication Critical patent/CN1712057A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a preparation of succinic acid carbobenzoxy derivative of orchid family plant effective part. The effective part, which containing more than 50% succinic acid carbobenzoxy derivative, is obtained by alcohol extraction, refining by different chromatography, purification. The obtained effective part is used to produce medicine which is enhancing intelligence and preventing senile dementia. The medicine dosage form contains injection, tablet, capsule, oral liquid or dropping pill.

Description

The preparation method of effective site-benzyl succinate derivative in the orchid
Technical field
The present invention relates to from orchid to extract, refining effective site and the extracting method thereof that obtains, and the effective site that is mainly the benzyl succinate compounds of utilizing the inventive method to obtain increases intelligence in preparation, prevents and treats the application in the disease medicament such as alzheimer disease.
Background technology
After the Literature Consult of system, find, from orchid, separate at present and obtain 17 benzyl succinate glycosides compounds, be present in recessed tongue Cymbidium (Coeloglossum), Herba Orchidis Latifoliae respectively and belong to (Orchis), Loroglossum genus, mountain Coral (Galeola), Gastrodia (Gastrodia) and all ages (seeing Table 1) in Cymbidium 6 platymisciums such as (Vanda)
Benzyl succinate glycosides compound in table 1 orchid
Numbering The chemical compound title The source List of references
??1 ??coelovirin?A ??a ??1
??2 ??coelovirin?B ??a ??1
??3 ??coelovirin?C ??a、b ??2-3
??4 ??coelovirin?D ??a ??2
??5 ??coelovirin?E ??a ??2
??6 ??loroglossin ??a、f、g、h ??3-6
??7 ??dactylorhhin?B ??a、b ??3
??8 ??dactylorhhin?C ??b ??3
??9 ??dactylorhhin?E ??a、b ??3
??10 ??4-(β-D-glucopyranosyloxyl) ??benzyl(S)-2-sec-isopropylmalate ??c ??7
??11 ??bis[4-(β-D-glucopyranosyloxyl) ??benzyl](S)-2-sec-isopropylmalate ??f、c ??7-9
??12 ??bis[4-(β-D-glucopyranosyloxyl) ??benzyl(S)-2-sec-butyl?malate. ??f ??9-10
??13 ??militarine ??b、g ??3,6,11
??14 ??dactylorhhin?A ??b ??3
??15 ??parishin?B ??d ??10
??16 ??parishin?C ??d ??10
??17 ??parishin ??d、i ??6,10,12-14
A: the blue Coeloglossum viride of long luxuriant recessed tongue; B: wide leaf Herba Orchidis Latifoliae Orchis latifolia; C:Galeolaseptentrionalis; D: Rhizoma Gastrodiae Galeola elata; E:Loroglossum hircinum; F: crawley-root Galeolafaberi; G:Orchis militaris; H:Orchis papilionacea; I:Vanda parishii;
The chemical constitution of 17 kinds of benzyl succinate glycosides compounds is as follows in the orchid:
Figure A20051008126400041
From orchid, separate 17 benzyl succinate glycosides compounds that obtain, usually adopt positive to separate with reverse phase silica gel, obtain monomeric compound, but find to have bibliographical information or the relevant patent that increases intelligence and effective site of preventing and treating the alzheimer disease effect (benzyl succinate glycosides compound) and preparation method thereof (effective ingredient-benzyl succinate glycosides compound in effective site content greater than 50%).
List of references
1?Huang?S.Y.,Shi?J.G.,Yang?Y.C.et?al.Two?new?isobutyltartrate?monoesters?fromCoeloglossum?viride?(L.)?Harm.var.bracteatum(Willd.)Richter.Chinese?ChemicalLetters,2002,13(6):551-554.
2?Huang?S.Y.,Shi?J.G.,Yang?Y.C.et?al.Two?new?isobutyltartrate?glucosides?fromCoeloglossum?viride(L.)Harm.var.bracteatum(Willd.)Richter.Chinese?ChemicalLetters,2003,14(8):814.
3?Kizu?H.,Kaneko?E.,Tomimori?T..?Study?on?Nepal?crude?drugs.X?X?VI.Chemicalconstituents?of?Panch?Aunle,the?roots?of?Dactylorhiza?hatagirea?D.Don.Chem.Pharm.Bull.,1999,47(11):1618-1625.
4?Pagani,F.Phytoconstituents?of?Orchidaceae.II.Isolation?and?identification?ofloroglossin?and?of?some?flavonol?heterosides?from?Orchis?papilionacea?L.Boll.Chim.Farm.,1982,121(4):174-177.
5?Gray?R.W.,Guggisberg?A,Segebarth?K.P.et?a1.Organic?natural?products.Theconstitution?of?loroglossine.Helv.Chim.Acta,1977,60(4):1304-11.
6?Aasen?A.,Behr?D.,Leanker?K.Orchidaceae?glycosides.Structure?of?loroglossine?andmilitarine,two?glucosides?from?Orchis?militaris.Acta?Chem.Scand.,Ser.B,1975,29(10):1002-4.
7?Inoue?S.,Wakai?A.,Konishi?T.et?al.Studies?on?Galeola?septentrionalis?Reichb.Fil.I.Isolation?and?structures?of?the?constituents?of“Dotuusoo”.YakukakuZasshi,1984,104(1):42-49.
8?Li?Y.M.,Zhou?Z.1.,Hong?Y.F.New?phenolic?derivatives?from?Galeola?faberi.PlantaMed.1993,59(4):363-5.
9 Lee cure bright, all tall and erect wheels, big vast Yongfu. crawley-root phenols The Chemical Constituents. and Acta Pharmaceutica Sinica, 1993,28 (10): 766-771.
10?Lin?J.H.,Liu?Y.C.,Hau?J.P.,et?al.Parishins?B?and?C?from?rhizomes?of?Gastrodiaelata.Phytochemistry,1996,42(2):549-551.
11?Appolonia?C.,Marston?A.Hostettmann?K.Additional?constituents?of?Orchis?militaris.J.Nat.Prod.,1986,49(4):725.
12 weeks are pretty, Chongqing, Hunan, Pu, Yang Yanbin.Nine kinds of phenolic constituents of fresh gastrodia elata.Science Bulletin, 1981,26 (18): 1118-1120..
13?Dahmen?J.,Leander?K.Studies?on?Orchidaceae?glucosides.Part?7.The?structure?ofparishin,a?glucoside?from?Vanda?parishii.Phytochemistry,1976,15(12):1986-7.
14?Taguchi?H.,Yosioka?I.,Yamasaki?K.,et?al.Studies?on?the?constituents?of?Gastrodiaelata?Blume.Chem.Pharm.Bull.,1981,29(1):55-62.
Summary of the invention
The objective of the invention is to extract, refiningly have the effective site (benzyl succinate glycosides compound) that increases intelligence and prevent and treat the alzheimer disease effect at the defective of above-mentioned existence and not enough providing from the orchid family contains the plant of benzyl succinate glycosides compound, its preparation method makes effective ingredient-benzyl succinate glycosides compounds content greater than 50%).
Another object of the present invention provides above-mentioned effective site and the application of preparation in pharmaceutical field thereof, particularly prevents and treats the application in the disease medicaments such as alzheimer disease in preparation.The present invention realizes by following technological process:
1 extracting method:
Crude drug is pulverized the back and is extracted with solvent (alcoholic solution of 50% above concentration), concentrates promptly to get extracting solution.
2 process for purification:
The a extracting solution is refining through styrene tyle macroporous adsorption resin, adopts water and alcoholic solution gradient elution, and middle part alcoholic solution eluting promptly gets effective site.
The b extracting solution is refining through reverse phase silica gel, adopts the alcoholic solution of water and low concentration to remove water-solubility impurity, adopts the alcoholic solution eluting of intermediate concentration promptly to get effective site again.
The c extracting solution is refining through purification on normal-phase silica gel, adopts the solvent method eluting.With low, medium polar solvent eluting weeding of grease solubility impurity, the big solvent elution of reuse polarity promptly gets effective site earlier.
Detect through HPLC, wherein effective ingredient-the content of benzyl succinate glycosides compound in effective site is all greater than 50%.
The effective site of utilizing the inventive method to obtain is rich in effective ingredient-benzyl succinate glycosides compound.
The effective site of utilizing the inventive method to obtain can be used for preparing said preparation on the pharmaceutics, for example: injection, tablet, capsule, oral liquid or drop pill etc.
When the effective site of utilizing the inventive method to obtain prepares the various dosage form of required medicine, can be according to the conventional production method preparation of pharmaceutical field.
The specific embodiment
The following examples can further specify the present invention, but do not limit the present invention in any way.
Embodiment 1:
1. extract Rhizoma Gymnadeniae medical material 1kg and pulverize, add after 95% soak with ethanol spends the night heating and refluxing extraction 3 times, each 2.0 hours.Merge extractive liquid, reclaims ethanol and also is concentrated into thick extractum, adds the distilled water heating for dissolving, is cooled to room temperature, leaves standstill 24 hours, centrifugally gets rid of filter, clear filtrate.
2. refining above-mentioned filtrate is passed through treated HPD-100 macroporous adsorbent resin, first water and ethanol gradient elution, and the middle part decompression recycling ethanol, spray drying promptly gets effective site 2.86g.Wherein active constituent content 52.6%.
Embodiment 2:
1. extract Rhizoma Gymnadeniae medical material 1kg and pulverize, add after 95% soak with ethanol spends the night heating and refluxing extraction 3 times, each 2.0 hours.Merge extractive liquid, reclaims ethanol and also is concentrated into thick extractum, adds the distilled water heating for dissolving, is cooled to room temperature, leaves standstill 24 hours, centrifugally gets rid of filter, clear filtrate.Concentrating under reduced pressure gets concentrated solution.
2. refining concentrated solution passes through the reverse phase silica gel post, behind water and the 10% alcoholic solution eluting, and the alcoholic solution eluting of reuse 50% concentration, concentrating under reduced pressure, the dry effective site 2.32g that gets.Active constituent content 65.3%.
Embodiment 3:
1. extract Rhizoma Gymnadeniae medical material 1kg and pulverize, add after 95% soak with ethanol spends the night heating and refluxing extraction 3 times, each 2.0 hours.Merge extractive liquid, reclaims ethanol and is concentrated into thick extractum.2. refining extractum silica gel mixed sample, by normal phase silicagel column, behind chloroform-methanol (9: the 1) eluting, reuse chloroform-methanol (1: 1) eluting, the effective site 2.59g of eluent reclaim under reduced pressure.Active constituent content 54.0%.
Prepare the effective site of the orchid family 6 kind of plant with above extraction and process for purification, detect through HPLC, wherein effective ingredient-the content of benzyl succinate glycosides compound in effective site is all greater than 50% (seeing Table 2).The effective site that is feedstock production with Rhizoma Gymnadeniae and recessed tongue orchid wherein, its effective ingredient-benzyl succinate glycosides compounds content is higher, and effect is best.Adopting macroporous adsorbent resin, reverse phase silica gel and purification on normal-phase silica gel to carry out effective site and make with extra care, is good with the reverse phase silica gel method, and effective ingredient-benzyl succinate glycosides compounds content is the highest in the effective site; But be more suitable in suitability for industrialized production with the macroporous adsorbent resin method is refining.
The different plants of table 2 the orchid family benzyl succinate glycosides compounds content (%) in the effective site after making with extra care
Process for purification Recessed tongue orchid Rhizoma Gymnadeniae Gymnadenia crassinervis Finet Wide leaf Herba Orchidis Latifoliae Beautiful oecoeclades falcata Crawley-root
Macroporous adsorbent resin ??52.3 ??52.6 ??51.3 ??50.6 ??50.8 ??50.1
Reverse phase silica gel ??62.1 ??65.3 ??60.9 ??62.5 ??59.6 ??56.2
Purification on normal-phase silica gel ??53.7 ??54.0 ??52.2 ??53.4 ??51.7 ??51.6

Claims (9)

1. the method for preparing orchid effective site is characterized in that this method comprises the following steps: successively
(1) crude drug (the orchid family contains the plant of benzyl succinate glycosides compound) is pulverized, used alcoholic solution room temperature or the heating and refluxing extraction of solvent 50-95% then, extracting solution gets thick extractum through normal pressure or concentrating under reduced pressure;
(2) this extractum, purification refining through various chromatography methods obtains the benzyl succinate glycosides compounds content in the effective site more than 50%.
2. preparation method according to claim 1 is characterized in that used raw material is that the orchid family contains the plant of benzyl succinate compounds such as Rhizoma Gymnadeniae, recessed tongue orchid, gymnadenia crassinervis Finet, wide leaf Herba Orchidis Latifoliae, beautiful oecoeclades falcata, crawley-root etc.
3. preparation method according to claim 1 is characterized in that extracting used alcohol and is a kind of in methanol, ethanol, isopropyl alcohol or the n-butyl alcohol.
4. preparation method according to claim 1, it is characterized in that used refining, purification process are macroporous adsorption resin chromatography, purification on normal-phase silica gel and reversed-phase silica gel chromatography, perhaps their combination is perhaps mixed extractum in silica gel or kieselguhr, dries the back with the organic solvent eluting that refluxes.
5. preparation method according to claim 1 is characterized in that the used solvent of eluting is a kind of or several mixed solvents in petroleum ether, toluene, benzene, ether, chloroform, dichloromethane, ethyl acetate, isopropyl alcohol, n-butyl alcohol, acetone, ethanol, methanol, the water.
6. use the effective site of the either party's method preparation described in the claim 1-5.
7. orchid effective site according to claim 6 is characterized in that wherein the benzyl succinate glycosides compounds content is more than 50%.Main effective ingredient is the benzyl succinate compounds, its effective ingredient construction features is to contain succinic acid (tartaric acid, malic acid and citric acid etc.) and 4-O-β-D-glucopyranosyl phenethanol or glucose structure, connects with benzyl ester or glycosidic bond form between them.
8. effective site preparation method according to claim 6 is characterized in that being made into tablet, injection, capsule, oral liquid or drop pill.
9. effective site according to claim 6 increases intelligence in preparation, prevent and treat the application in the medicine of alzheimer disease.
CN 200510081264 2004-06-24 2005-06-24 Preparation of succinic acid carbobenzoxy derivative of orchid family plant effective part Pending CN1712057A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200510081264 CN1712057A (en) 2004-06-24 2005-06-24 Preparation of succinic acid carbobenzoxy derivative of orchid family plant effective part

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN200410049669.6 2004-06-24
CN200410049669 2004-06-24
CN 200510081264 CN1712057A (en) 2004-06-24 2005-06-24 Preparation of succinic acid carbobenzoxy derivative of orchid family plant effective part

Publications (1)

Publication Number Publication Date
CN1712057A true CN1712057A (en) 2005-12-28

Family

ID=35717965

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200510081264 Pending CN1712057A (en) 2004-06-24 2005-06-24 Preparation of succinic acid carbobenzoxy derivative of orchid family plant effective part

Country Status (1)

Country Link
CN (1) CN1712057A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104173741A (en) * 2013-05-28 2014-12-03 中国医学科学院药物研究所 Application of pseudobulubs cremastrae seu pleiones' effective part in treatment of senile dementia
CN107095963A (en) * 2016-02-26 2017-08-29 中国医学科学院药物研究所 Purposes of the bletilla active component in treatment senile dementia

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104173741A (en) * 2013-05-28 2014-12-03 中国医学科学院药物研究所 Application of pseudobulubs cremastrae seu pleiones' effective part in treatment of senile dementia
CN107095963A (en) * 2016-02-26 2017-08-29 中国医学科学院药物研究所 Purposes of the bletilla active component in treatment senile dementia

Similar Documents

Publication Publication Date Title
EP2329816B1 (en) An anti-cancer active substance from antrodia camphorata, method for preparing the same and use thereof
CN100575358C (en) Flos Lonicerae extract, its preparation method and application
CN101704857A (en) Process for separating and purifying special component specnuezhenide of glossy privet fruit
CN105998103A (en) Chestnut flower activated extract and preparation method and application thereof
CN109694366B (en) Method for separating and purifying active ingredients of clematis filamentosa dunn
CN104926825B (en) Neolignan alkane derivatives promoting neurotrophic activity, and preparation method and application thereof
CN1534040A (en) Preparation method of hongjintian effective component extract
CN101032537A (en) Gynura procumbens (Lour.) Merr. Flavonoid substances preparing method and the application
CN107929544B (en) Preparation method and application of mileanine part and monomer in bletilla plants
CN1709417A (en) Ainsliaea fragrans champ extract and its preparing method
CN1712057A (en) Preparation of succinic acid carbobenzoxy derivative of orchid family plant effective part
CN105175426B (en) A kind of method of the extraction purification Bergenin from treebine stem
CN115872960A (en) Sesquiterpene and dimer compound, and preparation method and application thereof
CN113248360B (en) Sesquiterpene piletatepene C and application thereof in preparation of drugs for treating antibiotic-associated diarrhea
KR100678490B1 (en) An isolation method of ginsenoside panaxadiol and panaxatriol
CN108892657B (en) Iridoid ester compound, preparation method and application thereof
CN108948040B (en) Gilmaxane type sesquiterpene compound extracted from herba Centellae and application thereof
CN115490660B (en) Artemisia annua lactone A-D and pharmaceutical composition and application thereof
CN116098930B (en) Separation and enrichment method for preparing high-purity eucommia ulmoides leaf total flavonoids and application thereof
CN110452278A (en) Smelly seven secondary metabolites and preparation method thereof and its application in pharmacy
CN110172016B (en) Benzyl alcohol compound, pharmaceutical composition and application thereof
CN110294786B (en) Preparation method of extractive of glabrous sarcandra herb stem
CN115558011B (en) Anthracene ketone compound and preparation method and application thereof
CN115703753B (en) Benzofuran derivative and preparation method and application thereof
CN112876366B (en) Broom-like isoesterasum, preparation method and application thereof, and pharmaceutical composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20051228